Breaking news from #SABCS25: Results from the decade-long WISDOM trial are reshaping what we know about breast cancer screening. Researchers compared annual mammography to a personalized, risk-based approach—using comprehensive risk assessment, including genetic testing, to guide when to start, how often to screen, and who may benefit most from prevention strategies. According to BCRF investigator Dr. Laura Esserman, this tailored model aims to ensure women receive screening at the frequency and